A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgens
- 1 December 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 173 (2) , 534-540
- https://doi.org/10.1016/s0006-291x(05)80067-1
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- The human androgen receptor: Domain structure, genomic organization and regulation of expressionPublished by Elsevier ,2003
- Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: High affinity for progestagenic and estrogenic steroidsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
- Characterization of polyclonal antibodies against the N-terminal domain of the human androgen receptorMolecular and Cellular Endocrinology, 1989
- The human androgen receptor is a 110 kDa proteinMolecular and Cellular Endocrinology, 1989
- Gene regulation by steroid hormonesCell, 1989
- Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroidsInternational Journal of Cancer, 1988
- A simple phase-extraction assay for chloramphenicol acyltransferase activityGene, 1988
- Pharmacology of antiandrogensJournal of Steroid Biochemistry, 1986
- The design and use of sex-steroid antagonistsJournal of Steroid Biochemistry, 1986
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979